The Journal of Heart and Lung Transplantation
Volume 21, Issue 11 , Pages 1237-1241 , November 2002

Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin

  • Paul Casey, MBChB

      Affiliations

    • Department of Respiratory Medicine, Green Lane Hospital, Auckland, New Zealand
    • ,
  • Jeff Garrett, MBChB, FRACP

      Affiliations

    • Department of Respiratory Medicine, Green Lane Hospital, Auckland, New Zealand
    • Corresponding Author InformationReprint requests: A. Prof. Jeff Garrett, Department of Respiratory Medicine, Green Lane Hospital, Auckland, New Zealand. Telephone: 64-9-5249055. Fax: 64-9-6310712
    • ,
  • Tam Eaton, MBChB, FRACP

      Affiliations

    • Department of Respiratory Medicine, Green Lane Hospital, Auckland, New Zealand

Received 19 July 2001 ,Accepted 19 February 2002.

References 

  1. Egan JJ, Yonan N, Carroll KB, Deiraniya AK, et al.  Allergic bronchopulmonary aspergillosis in lung allograft recipients. Eur Respir J. 1996;9:169–171
  2. Fitzsimmons EJ, Aris R, Patterson R. Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient. Chest. 1997;112:281–282
  3. International guidelines for the selection of lung transplant candidates. Auckland, New Zealand: American Thoracic Society; 1998;
  4. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest. 1994;105:32–36
  5. Hanley-Lopez J, Clement LT. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med. 2000;6:540–544
  6. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis (Role of atropy and response to itraconazole). Chest. 1999;115:364–370
  7. Schwartz RH, Hollick GE. Allergic bronchopulmonary aspergillosis with low serum immunoglobulin E. J Allerg Immunol. 1981;68:290–294
  8. Maiz L, Cuevas M, Quirce S, Pacheco A, et al.  Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis. J Allerg Clin Immunol. 1997;100:431–432
  9. Zeaske R, Bruns T, Fink JN, et al.  Immune responses to Aspergillus in cystic fibrosis. J Allerg Clin Immunol. 1988;82:73–77
  10. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serological and radiological criteria in patients at risk. J Lab Clin Med. 1991;117:138–142
  11. Salez F, Brichet A, Desurmont S, Grosbois JM, et al.  Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest. 1999;116:1665–1668
  12. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, et al.  A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342:756–762
  13. Purcell IF, Corris PA. Use of nebulised amphotericin B in the treatment of Aspergillus fumigatus empyema. Thorax. 1995;50:1321–1323
  14. Cafferkey MT. Chemoprophylaxis of invasive pulmonary aspergillosis. J Antimicrob Chemother. 1994;33:917–924
  15. Calvo V, Borro JM, Morales P, Morcillo A, et al.  Antifungal prophylaxis during the early postoperative period of lung transplantation. Chest. 1999;115:1301–1304
  16. Gryn J, Goldberg J, Johnson E, Siegel J, Inzerillo J. The toxicity of daily inhaled amphotericin B. Am J Clin Oncol. 1993;16:43–46
  17. Cory DB, Grunig G, Hadeiba H, Kurup VP, et al.  Requirements for allergen induced airway hypereactivity in T and B cell deficient mice. Mol Med. 1998;4:344
  18. Prescott SL, Macaubus C, Smallacombe T, Holt BJ, et al.  Development of allergen specific T-cell memory in atopic and normal children. Lancet. 1999;353:196–200
  19. Kauffman HF, Tomee JFC, van de Reit MA, Timmerman AJB, et al.  Protease-dependant activation of epithelial cells by fungal allergens leads to morphological changes and cytokine productions. J Allerg Clin Immunol. 2000;105:1185–1193
  20. Wark P, Saltos N, Simpson J, Slater S, et al.  Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J. 2000;16:1095–1101
  21. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, et al.  Effect of high dose inhaled steroids on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1635–1639

PII: S1053-2498(02)00425-4

The Journal of Heart and Lung Transplantation
Volume 21, Issue 11 , Pages 1237-1241 , November 2002

Article Tools

* Image Usage & Resolution